(Q30372990)

17 August 2017

Elicitation of protective immune responses using a bivalent H5N1 VLP vaccine. (English)

1 reference

17 August 2017

2

Ted M Ross

1 reference

17 August 2017

Corey J Crevar

1

1 reference

17 August 2017

28 October 2008

1 reference

17 August 2017

1 reference

17 August 2017

5

1 reference

17 August 2017

131

1 reference

Seasonal inactivated influenza virus vaccines

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583969

Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle

4 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583969

Antigenic profile of avian H5N1 viruses in Asia from 2002 to 2007.

4 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583969

Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin

4 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583969

Lentivirus-like particles without reverse transcriptase elicit efficient immune responses

4 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583969

Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines

4 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583969

Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice.

4 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583969

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

4 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583969

Impact of glycosylation on the immunogenicity of a DNA-based influenza H5 HA vaccine

4 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583969

Induction of heterosubtypic immunity to influenza A virus using a DNA vaccine expressing hemagglutinin-C3d fusion proteins

4 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583969

Fc receptor-mediated phagocytosis makes a significant contribution to clearance of influenza virus infections

4 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583969

C3d enhancement of antibodies to hemagglutinin accelerates protection against influenza virus challenge

4 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583969

Role of the B-cell response in recovery of mice from primary influenza virus infection

4 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583969

Binding of monomeric immunoglobulins to Fc receptors of mouse macrophages

4 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583969

Receptors for IgG: subclass specificity of receptors on different mouse cell types and the definition of two distinct receptors on a macrophage cell line

4 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583969

Characterization of a DNA vaccine expressing a human immunodeficiency virus-like particle

4 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1743-422X-5-131

Mouse strain-dependent differences in enhancement of immune responses by C3d.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1743-422X-5-131

Live attenuated influenza vaccine is safe and immunogenic in immunocompromised ferrets

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1743-422X-5-131

Membrane embedded HIV-1 envelope on the surface of a virus-like particle elicits broader immune responses than soluble envelopes

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2583969

Efficacy of Human Papillomavirus-16 Vaccine to Prevent Cervical Intraepithelial Neoplasia

26 November 2018

1 reference

12 December 2020

Combined human papillomavirus DNA and human papillomavirus-like particle serologic assay to identify women at risk for high-grade cervical intraepithelial neoplasia

1 reference

12 December 2020

Activation of mouse complement by monoclonal mouse antibodies

1 reference

12 December 2020

Divergent roles for Fc receptors and complement in vivo

1 reference

12 December 2020

Identifiers

DOI

10.1186/1743-422X-5-131

1 reference

PMC publication ID

2583969

Dimensions Publication ID

17 August 2017

0 references

1 reference

PMC publication ID

2583969

17 August 2017

PubMed publication ID

18957098

1 reference

PMC publication ID

2583969